In the orthotopic pancreatic cancer model, DNAse I treatment also strongly inhibited tumor burden and tumor metastasis to the liver and diaphragm, confirming the important pathological role of extracellular DNA in pancreatic cancer. Here, DNASE1L3 is linked to familial pancreatic carcinoma.